Rocket Doctor AI

Rocket Doctor AI CROIC

Delisted

The Cash Return on Invested Capital (CROIC) of Rocket Doctor AI (TRUE.CN) as of Nov 16, 2026 is -469.95 %. In the previous year, Cash Return on Invested Capital (CROIC) was 482.78 % — a change of -197.34% (lower).

CROIC

-469.95 %

YoY

-197.34%

Last updated:

Cash Return on Invested Capital (CROIC) of Rocket Doctor AI is 2024 -469.95 % . Cash Return on Invested Capital (CROIC) of Rocket Doctor AI was 2023 482.78 % . It decreases by -197.34% lower compared to the previous year.

The Rocket Doctor AI CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2017
213.04 CAD
Jan 1, 2018
-1,074.00 CAD
Jan 1, 2019
-145.59 CAD
Jan 1, 2020
764.22 CAD
Jan 1, 2021
-5,723.66 CAD
Jan 1, 2022
89.88 CAD
Jan 1, 2023
482.78 CAD
Jan 1, 2024
-469.95 CAD
The Rocket Doctor AI CROIC history
YEARCROICYoY
-469.95 %-197.34%
482.78 %+437.15%
89.88 %-101.57%
-5,723.66 %-848.95%
764.22 %-624.93%
-145.59 %-86.44%
-1,074.00 %-604.12%
213.04 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Rocket Doctor AI Stock analysis

What does Rocket Doctor AI do? Treatment.com AI Inc generates revenue through its Treatment Digital Health App, a symptom assessment tool developed by a global team of doctors and engineers. The app provides predictive health insights using disease rate estimates, geographic variation data, and medical research, targeting patients and caregivers seeking informed health decisions. The company also offers medical education solutions and clinical advisor services, serving healthcare professionals and institutions globally. Revenue streams include subscriptions for app access and tailored medical education programs. The Treatment Digital Health App is designed for widespread use, offering advanced medical knowledge access to users worldwide. Medical clinic solutions are integrated into the platform, supporting healthcare providers in decision-making. Clinical advisor services leverage the AI platform to assist clinics and institutions with specialized medical guidance. These offerings are marketed to healthcare consumers, clinics, and educational institutions as part of the company's global healthcare technology strategy. Treatment.com AI Inc's business model focuses on AI-driven health solutions, with the Treatment Digital Health App as its primary product. The app's predictive health assessments are updated regularly by medical professionals, ensuring relevance and accuracy. The company monetizes through direct consumer subscriptions and B2B partnerships with medical clinics and educational providers, emphasizing global accessibility and evidence-based medical insights. Rocket Doctor AI is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rocket Doctor AI stock

Cash Return on Invested Capital (CROIC) of Rocket Doctor AI is -469.95 % in 2024.

Cash Return on Invested Capital (CROIC) of Rocket Doctor AI changed from 482.78 % to -469.95 %, representing a -197.34% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Rocket Doctor AI since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Rocket Doctor AI with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Rocket Doctor AI

All Key Metrics — Rocket Doctor AI